Company news
Compugen Ltd. news in 2019
Compugen Ltd.'s news releases, calls and decks from 2019, newest first.
Compugen Added to the NASDAQ Biotechnology Index
December 19, 2019
Compugen Reports Third Quarter 2019 Results
November 10, 2019
Compugen Expands Patent Portfolio for COM902 with New Composition of Matter and Use Patent in Europe
November 5, 2019
Compugen Presents Preclinical Data for COM902 Anti-TIGIT Program at SITC 2019
November 4, 2019
Compugen Presents Initial Clinical Data from Ongoing Phase 1 Trial of COM701 in Patients with Advanced Solid Tumors at SITC 2019
November 4, 2019
Compugen Announces FDA Clearance of IND Application for COM902
November 3, 2019
Compugen to Release Third Quarter 2019 Results on Monday, November 11, 2019
October 27, 2019
Compugen to Present Data from Ongoing COM701 Phase 1 Clinical Trial at SITC 2019
October 1, 2019
Compugen Presents Update on COM701 Phase 1 Study at 2019 IGCS
September 18, 2019
Compugen Reports Second Quarter 2019 Results
August 4, 2019
Compugen Second Quarter 2019 Conference Call Scheduled for Monday, August 5, 2019 at 8: 30 AM ET
July 21, 2019
Compugen Expands Intellectual Property Portfolio for COM701 with New U.S. Patent Covering Combination Use with anti-PD-1 Antibody
July 15, 2019
Compugen Appoints Eran Perry to Its Board of Directors
July 1, 2019
Compugen to Present at the Jefferies 2019 Healthcare Conference
May 21, 2019
Compugen First Quarter 2019 Conference Call Scheduled for Monday, May 20, 2019 at 8: 30 AM ET
May 5, 2019
Compugen Presents Update on COM701 Phase 1 Trial at the 2019 AACR Annual Meeting
April 2, 2019